Vessi Medical brings a new approach to treat Non-Muscle-Invasive Bladder Cancer (NMIBC) utilizing bladder-specific cryotherapy technology.
Vessi Medical has raised €1.4M across 1 funding round from 1 investor, most recently a round in Aug 2020. Based in Misgav, Israel; founded 2015; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-08-31 | Other | €1.4M |
| Trendlines Group |
| View deal → |
